Abstract
In a seminal report in 1997, Asahara and colleagues[1][1] first described the existence of endothelial progenitor cells (EPCs) in human peripheral blood (PB) CD34+ mononuclear cell (MNC) fraction. In a subsequent report,[2][2] they described the ability of bone marrow (BM)-derived circulating EPCs
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
